Das Sisyphus-Syndrom im Gesundheitswesen: Neue Evidenz
AbstractHealth care may be similar to the work Sisyphus, a Greek hero who was condemned by the Gods to push a big rock up a hill only to see it slip out of his hands before making it to the top. To see why there my be a Sisyphus syndrome in health, consider an initial decision to devote more resources to health. The likely consequence is an increased number of survivors, who exert political pressure in favor of even more health care. If they succeed, the cycle goes into its next round and might even prove explosive. Earlier research failed to identify this political feedback in industrial countries. Using improved model formulation, data, and econometric methodology, this contribution does find evidence suggesting the existence of a Sisyphus syndrome. However, the good news is that the cycle seems to be dampened rather than explosive.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoArticle provided by Justus-Liebig University Giessen, Department of Statistics and Economics in its journal Journal of Economics and Statistics.
Volume (Year): 227 (2007)
Issue (Month): 5+6 (December)
Contact details of provider:
Postal: Licher Straße 74, 35394 Gießen
Phone: +49 (0)641 99 22 001
Fax: +49 (0)641 99 22 009
Web page: http://wiwi.uni-giessen.de/home/oekonometrie/Jahrbuecher/
More information through EDIRC
Production of health; health care expenditure; dynamic feed back; Sisyphus syndrome;
Find related papers by JEL classification:
- I10 - Health, Education, and Welfare - - Health - - - General
- J10 - Labor and Demographic Economics - - Demographic Economics - - - General
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Peter Zweifel & Stefan Felder & Markus Meiers, 1999. "Ageing of population and health care expenditure: a red herring?," Health Economics, John Wiley & Sons, Ltd., vol. 8(6), pages 485-496.
- Gerdtham, Ulf-G. & Jonsson, Bengt, 1991. "Conversion factor instability in international comparisons of health care expenditure," Journal of Health Economics, Elsevier, vol. 10(2), pages 227-234, July.
- Gerdtham, Ulf-G. & Ruhm, Christopher J., 2006.
"Deaths rise in good economic times: Evidence from the OECD,"
Economics & Human Biology,
Elsevier, vol. 4(3), pages 298-316, December.
- Gerdtham, Ulf-G. & Ruhm, Christopher J., 2002. "Deaths Rise in Good Economic Times: Evidence From the OECD," IZA Discussion Papers 654, Institute for the Study of Labor (IZA).
- Ulf-G. Gerdtham & Christopher J. Ruhm, 2002. "Deaths Rise in Good Economic Times: Evidence From the OECD," NBER Working Papers 9357, National Bureau of Economic Research, Inc.
- Grossman, Michael, 2000. "The human capital model," Handbook of Health Economics, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 7, pages 347-408 Elsevier.
- J. A. Hausman, 1976.
"Specification Tests in Econometrics,"
185, Massachusetts Institute of Technology (MIT), Department of Economics.
- Friedrich Breyer & Volker Ulrich, 2000. "Gesundheitsausgaben, Alter und medizinischer Fortschritt: Eine Regressionsanalyse," Journal of Economics and Statistics (Jahrbuecher fuer Nationaloekonomie und Statistik), Justus-Liebig University Giessen, Department of Statistics and Economics, vol. 220(1), pages 1-17.
- Pedro Pita Barros, 1998. "The black box of health care expenditure growth determinants," Health Economics, John Wiley & Sons, Ltd., vol. 7(6), pages 533-544.
- Frech, H. E. III & Miller, Richard D. Jr., 1996. "The Productivity of Health Care and Pharmaceuticals: An International Comparison," University of California at Los Angeles, Research Program in Pharmaceutical Economics and Policy qt0d90459k, Research Program in Pharmaceutical Economics and Policy, UCLA.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Peter Winker).
If references are entirely missing, you can add them using this form.